HealthQuill Articles by: HealthQuill
nasal spray
Drugs

Eli Lilly just spent $3.8 billion on psychedelics. Here’s why

HQ Team July 23, 2026: Eli Lilly, the pharma company behind weight-loss blockbusters Mounjaro and Zepbound recently agreed to buy AtaiBeckley, a psychedelic

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs

Health benefits hype drive FDA to review 7 peptides and their sale

HQ Team July 23, 2026: Peptides, the short chains of amino acids that serve as the building blocks of proteins, are generating significant

Read More
Global health bodies in more than 100 nations are uniting to vaccinate children after COVID-19 waves severed supplies, shuttered clinics, and overburdened health services.
Drugs Health

US measles cases hit a 35-year high at 2,295

HQ Team July 22, 2026: The United States has recorded 2,295 measles cases,  the highest total in 35 years. The raw number is

Read More
Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor that may cure chronic pain without using opioids.
Drugs

FDA updated drug labelling regulations guide (2026)

HQ Team July 21, 2026: Every prescription drug sold in the United States carries labelling that the FDA treats as a legal document,

Read More
Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.
Pharma

The weight-loss drug race just got crowded

Jay Shankar July 21, 2026: Global obesity medicine sales hit $66 billion in 2025 and are on track to reach $92 billion this

Read More
The prevalence of JN.1, a Covid-19 sub-variant, has risen to 62% in the US on Jan. 5 compared to two weeks prior, according to the National Public Health Agency.
Health Research

Pandemic-born four-year-olds read well but struggle to focus: Study

July18,2026: One in three four-year-olds born during England’s first COVID-19 lockdown is struggling to focus, follow instructions, or manage frustration in the classroom

Read More
US regulator, the FDA has approved Gilead Sciences, Inc.'s supplemental new drug application for treating chronic hepatitis B virus in paediatric patients six years of age and older.
Drugs Health

Scientists map 641 new schizophrenia genes using “Social Network” for DNA

HQ Team June 24,2026: Scientists have discovered 641 previously unknown genes linked to schizophrenia, using a revolutionary method that maps how genes “talk” to

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs

New procedure, GAE, halves knee pain in osteoarthritis patients

HQ Team June 23, 2026: A minimally invasive procedure that blocks the small blood vessels supplying an arthritic knee can reduce pain by

Read More
India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of GlaxoSmithKline.
Drugs

Who is buying India’s hospitals and what it means for its 1.4 Billion people?

HQ Team Editor’s Note: The need for this story arose out of discussions on healthcare access difficulties in the developed world. Horror stories

Read More
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs

FDA approves Utebzi, first carbapenem pill for complicated UTIs

HQ Team June 17, 2026: The US Food and Drug Administration has approved Utebzi (tebipenem pivoxil), an antibiotic pill for people suffering from

Read More